99 related articles for article (PubMed ID: 33819231)
1. DCUN1D1 promotes tumour progress in prostate cancer and its effect on DU145 in vitro.
Huang S; Liu Z; Jiang F; He H; Zhong W
J Pak Med Assoc; 2021 Feb; 71(2(A)):473-478. PubMed ID: 33819231
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of SCCRO (DCUN1D1) in prostate cancer and its proliferation-inhibiting effect on Lncap cells.
Zhang ZH; Li J; Luo F; Wang YS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4283-4291. PubMed ID: 29077169
[TBL] [Abstract][Full Text] [Related]
3. [Expression of forkhead transcription factor O4 in prostate cancer and its effect on prostate cancer cell invasion].
Huang F; Li X; Du Q; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1194-1201. PubMed ID: 30643063
[TBL] [Abstract][Full Text] [Related]
4. DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway.
Vava A; Paccez JD; Wang Y; Gu X; Bhasin MK; Myers M; Soares NC; Libermann TA; Zerbini LF
Cells; 2023 Jul; 12(15):. PubMed ID: 37566052
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting Defective in Cullin Neddylation 1 Domain Containing 1 (DCUN1D1).
Xiao J; Li G; Zhou J; Wang S; Liu D; Shu G; Zhou J; Ren F
Oncol Res; 2018 May; 26(4):593-604. PubMed ID: 28470146
[TBL] [Abstract][Full Text] [Related]
7. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
Jiang Z; Song Q; Zeng R; Li J; Li J; Lin X; Chen X; Zhang J; Zheng Y
Oncotarget; 2016 Jul; 7(29):45622-45636. PubMed ID: 27285984
[TBL] [Abstract][Full Text] [Related]
10. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
11. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells.
Zhang S; Rong P; Chen Q; Wang W
Life Sci; 2019 Sep; 232():116626. PubMed ID: 31276688
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
14. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells.
Kang R; Zhao S; Liu L; Li F; Li E; Luo L; Xu L; Wan S; Zhao Z
Cancer Cell Int; 2016; 16():20. PubMed ID: 26981049
[TBL] [Abstract][Full Text] [Related]
16. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
[TBL] [Abstract][Full Text] [Related]
17. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of TM4SF1 improves cell metastasis and growth by activating ERK1/2 signaling pathway in human prostate cancer.
Chen J; Wang F; Xu H; Chen D; Liu W; Wang J
J BUON; 2019; 24(6):2531-2538. PubMed ID: 31983129
[TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
[TBL] [Abstract][Full Text] [Related]
20. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
